Q3 2025 Codexis Inc Earnings Call Transcript

Nov 6, 2025 / 09:30 PM GMT

Release Date Price: $2.04 (-5.35%)

Transcript 10-Q8-K

Key Points

Positve

Codexis Inc (CDXS) signed a supply assurance agreement with Merck, providing a vital infusion of non-dilutive cash.
The company has 11 revenue-generating contracts with 40 more in the pipeline, indicating strong commercial momentum.
Codexis Inc (CDXS) is transitioning into a full-service manufacturing innovator, enhancing its capabilities in oligonucleotide manufacturing.
The company is set to sign a lease for a new facility, enabling GMP-grade manufacturing using eco-synthesis technologies.
The technical team has made significant progress in scaling the eco platform, with new data to be presented at Tides Europe.

Negative

Total revenues for the third quarter of 2025 decreased to $8.6 million from $12.8 million in the third quarter of 2024.
There is a strategic shift away from the historical small molecule biocatalysis business due to changing market dynamics and pricing pressures.
Research and development expenses increased to $13.9 million in Q3 2025 from $11.5 million in Q3 2024, driven by higher headcount and lab supply expenses.
The company experienced a net loss of $19.6 million for Q3 2025, slightly lower than the $20.6 million loss in Q3 2024.
Codexis Inc (CDXS) is undergoing a restructuring that includes reducing headcount across various groups to align with its new strategic focus.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CDXS.OQ - Codexis Inc
Q3 2025 Codexis Inc Earnings Call
Nov 06, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the to the Codexus third quarter 2025 earnings conference call.

At this time, all participants are in a listen-only mode. A question-and-answer session will follow a formal presentation.

If anyone should require operator assistance during this conference, please press 0 on your telephone keypad.

Please note that this conference is being recorded.

I will now turn the conference over to your host, Georgia Herbes, Chief Financial Officer.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.